Flagship Ventures Fund V, L.P.'s Net Worth
$360 Million
Who is Flagship Ventures Fund V, L.P.?
Flagship Ventures Fund V, L.P. has an estimated net worth of $360 Million. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Kaleido Biosciences, Inc., Omega Therapeutics, Inc., Foghorn Therapeutics Inc., Denali Therapeutics Inc., Rubius Therapeutics, Inc., Codiak BioSciences, Inc., Sigilon Therapeutics, Inc., and Evelo Biosciences, Inc..
SEC CIK
Flagship Ventures Fund V, L.P.'s CIK is 0001627639
Past Insider Trading and Trends
2020 was Flagship Ventures Fund V, L.P.'s most active year for acquiring shares with 17 total transactions. Flagship Ventures Fund V, L.P.'s most active month to acquire stocks was the month of February. 2023 was Flagship Ventures Fund V, L.P.'s most active year for disposing of shares, totalling 18 transactions. Flagship Ventures Fund V, L.P.'s most active month to dispose stocks was the month of July. 2021 saw Flagship Ventures Fund V, L.P. paying a total of $26,089,973.00 for 58,154,228 shares, this is the most they've acquired in one year. In 2023 Flagship Ventures Fund V, L.P. cashed out on 13,527,995 shares for a total of $17,962,115.86, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sana Biotechnology, Inc. (SANA) Snapshot price: $6.175
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -32.03% | -11.78M |
—
|
—
| 25M |
Sep 13
| |||
Form 4
| -3.22% | -403.76K |
$6.27 | -$2,532,858.32 | 12.12M |
Jun 6 - Jun 7
| |||
Form 4
| -4.17% | -545.24K |
$6.47 | -$3,527,275.14 | 12.53M |
May 24 - May 26
| |||
Form 4
|
∞
| 34.24M |
—
|
—
| 34.24M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kaleido Biosciences, Inc. (KLDO) Snapshot price: $0.000001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +47.12% | 12M |
$15.00 | $13,999,995.00 | 37.48M |
Mar 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Foghorn Therapeutics Inc. (FHTX) Snapshot price: $3.13
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 12.67M |
$16.00 |
—
| 12.67M |
Oct 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Denali Therapeutics Inc. (DNLI) Snapshot price: $17.18
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2,754.00% | 8.61M |
—
|
—
| 8.92M |
Dec 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Rubius Therapeutics, Inc. (RUBY) Snapshot price: $0.053
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.89% | 210K |
$29.00 | $6,090,000.00 | 23.89M |
Mar 19
| |||
Form 4
| +185.29% | 33.3M |
—
|
—
| 51.27M |
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||